Operator
Operator
At this time, I would like to welcome everyone to the International Flavors & Fragrances third quarter 2018 earnings conference all. All participants will be in a listen-only mode until the formal question-and-answer portion of the call. I would now like to introduce Michael DeVeau, Head of Investor Relations. You may begin. Michael DeVeau - International Flavors & Fragrances, Inc.: Thank you. Good morning, good afternoon, and good evening, everyone. Welcome to IFF's third quarter 2018 conference call. Yesterday evening, we distributed a press release announcing our financial results. A copy of the release can be found on our IR website at ir.iff.com. Please note that this call is being recorded live and will be available for replay on our website. Please take a moment to review our forward-looking statements. During the call, we'll be making forward-looking statements about the company's performance, particularly with regard to our outlook for the fourth quarter and full-year 2018. These statements are based on how we see things today and contain elements of uncertainty. For additional information concerning the factors that can cause actual results to differ materially from forward-looking statements, please refer to our cautionary statement and risk factors contained in our 10-K filed on February 27, 2018 and our press release that we filed yesterday. Today's presentation will include non-GAAP financial measures, which excludes those items that we believe affect comparability. A reconciliation of these non-GAAP financial measures to their respective GAAP measures is set forth in our press release and is on our website. With me on the call today is our Chairman and CEO, Andreas Fibig; and our Executive Vice President and CFO, Rich O'Leary. We will start with prepared remarks and then take any questions that you may have. With that, I would now like to introduce Andreas. Andreas Fibig - International Flavors & Fragrances, Inc.: Thank you, Mike. On the call today, we will review our financial results for the third quarter and the first nine months for 2018, give a quick update on Frutarom since the transaction has closed, and provide an update to all financial expectations for the full year, inclusive of Frutarom. Then we will be happy to take any questions that you may have. Starting with a recap of our first nine months performance, growth was strong across our key financial metrics. Currency neutral sales increase 6% year-to-date, with Flavors growing 6% and Fragrances growing 5%. New win performance and price increases to mitigate rising material cost, both contributed to consolidated growth. From a profitability perspective, currency neutral adjusted operating profit grew 4%, supported by volume leverage and our focus to drive greater efficiency throughout our business via cost and productivity initiatives. Currency neutral adjusted EPS improved 11%, driven by adjusted operating profit growth as well as a more favorable effective tax rate. Our strategic priorities continue to drive overall performance over the first nine months of 2018. Sales of our Re-Imagine Modulation portfolio grew strong double-digit and PowderPure grew an impressive triple-digits, both indicative of our position as a leader in innovation. Performance with local and regional customers remained strong, growing double that of our global customers, which on a consolidated basis is about 50% of our customer base. In Flavor specifically, our mid-size go-to-market platform, Tastepoint, continued to deliver strong results, improving strong double-digits in the first nine months of 2018. In terms of maximizing our portfolio towards our most margin accretive categories, cosmetic active ingredients continued its robust growth trend by improving double-digits. Also on the Fragrance side, hair care grew double-digits and home care and toiletries improved high-single digits. In Flavors, growth was strong in dairy and beverage, improving double-digits and high-single digits respectively. We also continue to focus on driving greater efficiencies throughout our business via cost and productivity initiatives, which allows us to reallocate resources to efforts that drive the greatest returns and maintain strong profitability. This yielded strong results in the first nine months of 2018. And so our cost and productivity initiatives, including zero-based budgeting added approximately 5 percentage points of gross to currency neutral adjusted operating profit and EPS growth. All-in-all, I'm very pleased with how well our refreshed priorities are performing and believe better positions us to drive long-term value for our shareholders. With that, I would like to turn the call over to Rich. [07BDC1-E Rich O'Leary]: Thanks, Andreas, and good morning, good afternoon, good evening to everyone. Moving on to our Q3 performance, currency neutral sales in the second quarter grew 4%. Growth was led by new wins and price increases to mitigate the impact of raw material cost inflation. From a profitability perspective, currency neutral adjusted operating profit increased 3% in the third quarter, as top line growth and the benefits associated with cost and productivity initiatives was offset by unfavorable price to input costs, inclusive of the BASF citral issue and weaker sales mix. Pricing was up more than 2 percentage points in the quarter on a consolidated basis. Despite the sequential acceleration in the third quarter, as expected, it did not offset raw material pressure, as we continue to see a timing lag in the Fragrance business unit. Currency neutral adjusted EPS increased 12%, as a more favorable year-over-year effective tax rate offset higher shares outstanding and interest expense associated with the equity and debt raise during the quarter. It should be noted that excluding the items that impact comparability, the adjusted tax rate for the third quarter of 2018 was 14% compared to 22.7% in the prior-year period. The year-over-year decrease was largely due to a more favorable mix of earnings, lower cost of repatriation, and the re-measurement of loss provisions, partially offset by adjustments to the impact of U.S. tax reform and the impact of current year transaction costs, including certain non-taxable gains on foreign currency in the prior year. Looking at the business unit performance for the third quarter, Flavors currency neutral sales increased 7% even against a strong year-ago comparison of 12%, with growth coming in all categories and all regions. On a two-year average basis, growth remained very strong at approximately 9.5%. North American Flavors improved 10% in the third quarter, led by double-digit growth at Tastepoint and strong performances in dairy and sweet. EAME increased 6% on a currency neutral basis, led by high-single digit growth in Europe as well as Africa and Middle East. Greater Asia grew 4% in the third quarter on a currency neutral basis, as it was led by double-digit growth in India and low-single digit increases in Indonesia, China, and ASEAN. Latin America increased 12% on a currency neutral basis, led by strong double-digit growth in Argentina as well as mid-single digit growth in Mexico. Flavors currency neutral segment profit grew approximately 7%, led primarily by volume growth and the benefits from ongoing cost and productivity initiatives. In terms of currency neutral segment profit margin, our profile remains strong at 22.1%. Fragrances currency neutral sales improved 2% on a strong year-ago double-digit comparison, with growth in nearly all regions. From a category perspective, Consumer Fragrances grew 2% on a currency neutral basis, as performance was driven by continued growth in hair, home, and fabric care. Fine Fragrances declined 2% on a currency neutral basis, against a very strong 18% comparison from the prior year. From a regional perspective, Greater Asia increased strong double-digits and EAME increased low-single digits. Fragrance Ingredients sales were up 5% on a currency neutral basis, led by strong double-digit growth in the cosmetic active ingredients business. This marks the ninth consecutive quarter of growth in Fragrance Ingredients. As we continue to successfully execute our refresh strategy and we achieve strong realization of price increases. From a profit perspective, Fragrances currency neutral segment profit decreased 5% on a currency neutral basis, as the benefits from productivity initiatives and cost management were more than offset by an unfavorable price to input costs, including the previously announced citral issue. In terms of currency neutral segment profit margins, our margins remains solid, yet were under pressure year-over-year. Before moving on, I'd like to provide some more commentary on the raw material environment, like I did in Q2. As you remember, coming into the year we expected mid-single-digit raw material inflation in 2018, inclusive of the impact of the citral situation, heavier in the business units versus Flavors. Since that time, cost inflation has picked up following a series of disruptions in the supply chain. Additional market disruptions continue to impact the Fragrance business unit, driven both by environmental considerations and new non-flavor and fragrance market demands for core raw materials. Unfortunately, we see further input cost and pressures in 2019, particularly in Fragrances. Our strategic priority is to protect our customers' business. However, this comes at a significant incremental cost and will require additional price increases as we move into 2019 to ensure we cover our raw material cost exposure. Operating cash flow was $202 million in first nine months of 2018 compared to $199 million in the prior-year period. This was primarily driven by litigation in the prior-year period. Core working capital was impacted by higher inventory to ensure continuity of supply during unprecedented supply chain challenges as well as higher raw material prices. From a capital allocation standpoint, we spent approximately $102 million in capital expenditures, or about 3.7% of sales, driven by new plant and capacity investments, mainly in Greater Asia. Some of these investments include a Flavors manufacturing facility in the Zhangjiagang Free Trade Zone, which opened on October 9, and a Natural Products Research lab located in the Nanjing Life Science Park, which opened on October 15. The Flavors plant is our second in China and is designed to supplement our existing flavors and manufacturing operations in Guangzhou. The Natural lab is our first outside of the U.S. China is a critical component of our long-term strategy. The opening of these new sites will support our efforts to be a partner of choice and to grow in this exciting region. We continue to believe that we will spend approximately 4% to 5% of sales for the full year 2018 on CapEx. Regarding cash returned to shareholders, during the first nine months, we spent approximately $163 million on dividends and $15 million on share repurchases. As a reminder, as part of the Frutarom combination, we paused our share repurchase program, as we will prioritize debt repayment going forward. We will continue to maintain a disciplined approach to capital allocation as we accelerate growth through organic investments and strategic acquisitions while returning significant capital to shareholders. Before turning it back to Andreas, I'd like to provide some commentary on Frutarom's estimated results for Q3 2018. Please note that this information is for informational purposes only, and they reflect Frutarom's results when it was under the previous ownership and prior to the completion of the acquisition on October 4. For the third quarter, net sales are expected to be between $360 million and $365 million, and adjusted EBITDA margin is expected to be approximately 21%. Performance from a top line perspective is expected to be up low single digits versus prior year, driven by the contribution of acquisitions and offset by foreign exchange headwinds. It should be noted that sales growth, while up year over year, was negatively impacted by customer order patterns, specifically in more commodity-oriented businesses such as trade and marketing and Frutarom's citrus processing business, which were both down double digits. Excluding these businesses, growth would have increased mid-single digits on a reported basis, and high single digits if we excluded foreign exchange impacts. In the third quarter, adjusted EBITDA margin continued to be solid, improving approximately 40 basis points year over year, led by gross margin improvements as well as expense control. On a year-to-date basis, sales are expected to be approximately $1.15 billion, an increase of about 15%. In terms of profitability, we expected adjusted EBITDA margin to be approximately 21.5%, which is a strong year-over-year improvement of approximately 175 basis points. With that, I'd like to turn the call back over to Andreas. Andreas Fibig - International Flavors & Fragrances, Inc.: Thank you, Rich. I would like now to give you a quick update on our Frutarom combination. I'm very happy to say that on October 4, we completed the combination with Frutarom. This is ahead of our original expectations of six to nine months from May 7 announcement. The coming together of IFF and Frutarom is a momentous achievement, and we're excited to be moving forward as one company while pursuing new opportunities that benefit all our stakeholders around the globe. I applaud the integration teams around the world that over the past several months have been working to ensure that we capture the best of both companies and create a seamless and efficient transition to achieve both our operational and financial targets for this combination. Together, we create a global leader in natural taste, scent, and nutrition. IFF has now a stronger product offering, broader access in attractive adjacencies, and stronger exposure to fast-growing customers. We expect to generate cost synergies of $145 million through raw material harmonization, footprint optimization, and streamlining overhead expenses by the third full year after the completion of the merger. Additionally, cross-selling opportunities and integrated solutions are expected to provide revenue synergies to our shareholders progressively over time. Through this combination, we are confident in the opportunities that lie ahead and the ability of the combination to accelerate financial performance and targeting sales growth an average of 5% to 7% and 10%-plus adjusted EPS growth, excluding total company amortization between 2019 and 2021, all on a currency neutral and pro forma basis. Let's take a look how the new IFF is positioned now that the transaction has been completed. As you can see from the slide, we instantly have the number two global market position in the industry, with approximately 33,000 customers globally, selling about 150,000 unique product solutions annually. Our organization is fueled by 13,000 hardworking employees in more than 110 manufacturing sites and approximately 100 R&D centers and labs around the world. This historic combination sets us up to service our customers like we never have done before, being able to offer them a stronger product offering to help them create differentiation in the marketplace. With the addition of Frutarom's offerings, we instantly become a leader and natural capabilities extending across our entire platform. Our combination creates a highly diversified portfolio, with exposure to fast-growing categories and customers. Being that our product offering is now extending beyond our traditional industry, we have renamed our business segments from Flavors and Fragrances to Taste and Scent respectively. To ensure we deliver a seamless experience to our newest customers, we intend to preserve Frutarom's best-in-class customer-facing capabilities, which will enable us to maintain the strong relationships Frutarom has built, while capturing this significant cross-selling opportunities we will have as a combined company. As a result, our intention is to report Frutarom as a standalone business unit. Based on projected pro forma 2018 sales, we expect Scent to be approximately 35%, Taste to be about 33% and Frutarom about 32% of our entire business. And now, looking at our Executive Leadership team, Matthias Haeni and Nicolas Mirzayantz will continue to lead our Taste and Scent division respectively. Leading the Frutarom division, I'm pleased to welcome Amos Anatot, who spent eight years at Frutarom in leadership positions, with his most recent role as Executive Vice President of Global Supply Chain and Operations. He has a great perspective of the taste, savory solutions, flavors and fragrance ingredients, Taura and trade & marketing businesses and that's been actively involved in integration as a leader from Frutarom. Within Frutarom, I would like also to welcome Yoni Glickman, who will run Natural Product Solutions, which includes health, colors and food protection. He most recently held the position of present Natural Solutions at Frutarom, where he led the company's natural food colors, antioxidants, cosmetics and health ingredients business. This leadership structure is in place since the 4th of October to run these businesses in a manner that leverage our strengths and supports our customers. Aligned with this approach, we are already capitalizing on a few quick wins. For example, leveraging our Tastepoint go-to-market strategy for small- and mid-size customers in North America, we are integrating Frutarom's North America taste business into our own. As a reminder, Tastepoint is designed to serve the dynamic and faster-growing middle-market customers in North America, a key driver of growth. By combining the Frutarom North America taste business with R&D, technology and consumer insight of IFF, we are strengthening the innovative go-to-market approach that targets unique needs and expectations of this subset of customers. As you have seen since inception, Tastepoint has been a success, evident by our strong growth with small- and mid-sized customers in North America. This transition should be seamless, as the go-to-market model used by Frutarom's North America flavors business is perfectly in line with what we have at Tastepoint. Another example is in cosmetic actives. While we are shifting Frutarom's cosmetic active ingredients business into our Lucas Meyer Cosmetics business. Established in 1995, Israeli Biotechnology Research or IBR researches, develops, manufactures, and markets innovative and proprietary natural active ingredients for the cosmetics and dietary supplement industries, mainly for cellular and skin anti-aging, skin protection from UV rays and air pollution, skin whitening, and pigmentation prevention. By combining these two businesses, we have strengthened our cosmetic active ingredients portfolio sold to some of the world's leading cosmetic companies. We believe this will support continued growth in this highly profitable category. And all of these measures we have started already since the closing of the deal, which is ahead of time. With that, I would like to ask Rich to provide some perspective for the full-year 2018 financials. [07BDC1-E Rich O'Leary]: Thank you, Andreas. Before providing full-year expectations, I wanted to clarify a few go-forward model assumptions. First, following the successful debt raise, our total debt outstanding is approximately $4.4 billion. The annual interest expense associated with this debt is expected to be between $150 million and $155 million per year. Currently, we expect our annual effective tax rate to be approximately 19%, more or less the average of the two standalone companies. For purposes of calculating adjusted diluted EPS on a go-forward basis, we estimate that there will be approximately 113 million diluted shares outstanding, including 6.3 million shares related to the tangible equity units. Annually amortization is expected to be approximately $220 million and subject to change based on the finalization of the purchase price accounting. In terms of our go-forward reporting, please note that we have modified the way we will disclose adjusted EPS. Previously, adjusted EPS was reported EPS excluding items that affect comparability. In addition to these exclusions, going forward, we will also exclude full amortization for the total company. We believe that this metric provides useful period-to-period comparisons of the results of our operational performance and cash generation capacity. Looking at the full year 2018, inclusive of Frutarom's fourth quarter estimated results, we are targeting year-over-year advancement in both top- and bottom-line results. We expect our sales to be between $3.95 billion and $4.05 billion for the full year, with similar contributions to Q3 in our legacy IFF business as well as sequential improvements in Frutarom sales performance versus the growth they achieved in Q3. We also expect our adjusted EPS to be between $6.25 and $6.45 excluding one-time items that may affect comparability and total company amortization for the full year. For reference purposes, we expect 2018 amortization for the full year to be approximately $83 million, made up of $37 million of legacy IFF amortization, $9 million from legacy Frutarom amortization, and an estimated $37 million from the purchase price accounting related to the (00:25:02) transaction. With that, let me turn it back over to Andreas for his final remarks. Andreas Fibig - International Flavors & Fragrances, Inc.: Thank you, Rich. In summary, we are pleased with a strong financial performance in the third quarter, as we achieved growth in all of our key financial metrics. Our strong performance in the first nine-months was driven by our refreshed priorities, as we continue to focus on the execution of our long-term strategy, accelerating growth, increasing differentiation and driving cost efficiencies to drive sustainable, profitable growth in the future and maximize value creation for our shareholders. As we look towards the remainder of the year, inclusive of Frutarom results for the fourth quarter, we expect strong advancements in top- and bottom-line results as noted by Rich. Looking forward, comes a bittersweet realization that the third quarter 2018 was our final as legacy IFF. We are now embarking on the next major chapter of IFF history. We believe that our combination with Frutarom, the largest transaction of its kind in our industry, is fundamentally going to expand our customer and employee base and product offerings. We will have greater exposure to fast-growing customers, broader access to attractive adjacencies and a very differentiated portfolio, with an increased focus on naturals and health and wellness, as well as more comprehensive solutions. We believe this will translate into accelerated financial performance as a combined company, with robust top- and bottom-line growth, leading to strong returns for our shareholders. With that, we would now like to open up the call to questions.